Superworth

Harrow EPS HROW

Diluted earnings per share by quarter and over the last twelve months, from 2010.

Last 12 months, to Jun 30, 2026
−$0.99
Latest quarter, Q2 FY26
−$0.46
−454% on a year earlier
Fiscal year 2025
−$0.16

Harrow's earnings per share was −$0.99 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was −$0.46, down 454% on the same quarter a year before.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2025−$0.16n/a
FY2024−$0.49n/a
FY2023−$0.75n/a
FY2022−$0.52n/a
FY2021−$0.68n/a
FY2020−$0.15n/a
FY2019−$0.01−102%
FY2018$0.53n/a
FY2017−$0.61n/a
FY2016−$1.51n/a
FY2015−$1.65n/a
FY2014−$1.11n/a
FY2013−$0.88n/a
FY2012−$2.10n/a
FY2011−$2.50n/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q2 FY26−$0.46−454%−$0.99
Q1 FY26−$0.74n/a−$0.40
Q4 FY25$0.18−5%−$0.16
Q3 FY25$0.03n/a−$0.15
Q2 FY25$0.13n/a−$0.30
Q1 FY25−$0.50n/a−$0.61
Q4 FY24$0.19n/a−$0.49
Q3 FY24−$0.12n/a−$0.94
Q2 FY24−$0.18n/a−$0.95
Q1 FY24−$0.38n/a−$0.91
Q4 FY23−$0.26−750%−$0.75
Q3 FY23−$0.13n/a−$0.45

Against its peers

Companies in Drug Manufacturers - General nearest Harrow's size, closest first, today.

CompanyEPS, 12 monthsGrowth
HROWHarrow−$0.99
AMPHAmphastar Pharmaceuticals$1.70−36% a year
OMEROmeros$1.52
ABUSArbutus Biopharma$0.78
PCRXPacira BioSciences$0.35
ANABAnaptysbio$4.57
COLLCollegium Pharmaceutical$1.24+19% a year
PAHCPhibro Animal Health$2.44+107% a year
ANIPANI Pharmaceuticals$4.70
CRMDCorMedix$2.13+184% a year
ZVRAZevra Therapeutics$0.93
Peer median$1.61

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on Harrow

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.